Navigation Links
Advanced Technologies Bring Record Growth to Charm Sciences in Its 35th Year
Date:2/19/2013

Lawrence, MA (PRWEB) February 19, 2013

As Charm Sciences celebrates its 35th year in business, its organic science continues to lead the world’s dairy and food processors in making the world a safer place to live. Charm—from its tests that detect antibiotics in milk to its hygiene verification test—provides the worldwide food processing industry with rapid and easy-to-use tests needed to keep contaminants out of food.

Charm ROSA® lateral flow tests, read on the Charm EZ® system, detect antibiotics in milk. On February 11, the US NCIMS (National Conference on Interstate Milk Shipments) approved the use of the EZ for milk testing. In the US, the 3-minute ROSA Charm® 3 SL3 test, run on the EZ, provides fast, accurate measurement of beta-lactam drugs in milk. Other ROSA tests detect each major class of antibiotic drugs used to treat dairy cows.

ROSA tests are also used in over 70 other countries to bring food safety testing to a new level of ease-of-use and accuracy. A reference laboratory for the European Union, the Institute for Agricultural and Fisheries Research (ILVO-T&V, Belgium), validated the following ROSA tests: MRLBL3, MRLBLRFTET2 (for Russian Federation), and MRLBLTET2. The MRLBL3 test detects beta-lactam in three minutes, and the MRLBLRFTET2 and MRLBLTET2 tests detect both beta-lactam and tetracycline drugs in two minutes.

Manufacturers also monitor mycotoxin levels in corn, wheat, milk, and other foods. Charm ROSA lateral flow tests are used worldwide, not just to detect antibiotics, but to detect mycotoxins. The USDA certifying laboratory GIPSA (Grain Inspection, Packers & Stockyards Administration) has approved the mycotoxin tests: AFPN, AFPN-BEST, AFQ-FAST, and AFQ-WET™ for aflatoxin; DONPN and DONQ-FAST5 for vomitoxin; FUM-FAST5 for fumonisin; OCHRAQ for ochratoxin, and ZEARQ for zearalenone. The AFQ-WET test uses Charm’s new Water Extraction Technology, which allows samples to be extracted with water. This eliminates ethanol and methanol and enables grain testers to discard negative tests in regular waste.

Charm’s hygiene verification products, the Charm novaLUM® and PocketSwab® Plus, have been cited by the U.S. Department of Veterans Affairs as the only verified test to be used in Veterans hospitals. This test quickly measures the amount of ATP on a surface, telling facilities managers if an area is clean.

The Charm novaLUM is primarily used in food manufacturing. Currently, multinational food manufacturers are setting up international regulations for all their facilities, using the Charm novaLUM to ensure a uniform quality food product worldwide.

Food manufacturers around the globe have partnered with Charm Sciences, resulting in sustained growth for over 35 years. Charm’s portfolio of products, which are constantly updated to meet regulatory and industry needs, truly make the world a safer place.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10428124.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Experimental Gel May Help Those With Advanced Parkinsons
2. Advanced genetic screening method may speed vaccine development
3. Advanced Prostate Cancer Drug May Help at Earlier Stage
4. Obese More Likely to Be Diagnosed With Advanced Thyroid Cancer
5. GW researchers discover biomarker for advanced bile duct fibrosis and bile duct cancer
6. San Francisco’s Advanced Male Medical Center Announces Discount, Discusses Erectile Dysfunction
7. Advanced Osteoarthritis Of The Knee Is Now Being Treated With Regenerative Medicine At The Center For Regenerative Medicine
8. Ecig Advanced Sponsors Lexington's First Annual Vaping Event
9. Lack of insurance linked to advanced stage cervical cancer
10. Clinical trial seeks to cure advanced Crohns disease using bone marrow transplant
11. Imaging Tests Up Among Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... Peoria, IL (PRWEB) , ... May 22, 2017 ... ... HealthCare, is part of a larger group investing in InsightRX, an early stage ... a patient’s underlying biological and pharmacological characteristics. Greatpoint Ventures Innovation Fund ...
(Date:5/21/2017)... FL (PRWEB) , ... May 20, 2017 , ... Pot. ... it, find it, review it, and share its attributes like never before. More than ... directory to connect cannabis enthusiasts to stores, strains, products – and for the first ...
(Date:5/21/2017)... ... May 21, 2017 , ... ... longer than six months since you've seen a dentist, it's time for a ... and getting x-rays once per year. , Dental checkups are a relatively easy ...
(Date:5/19/2017)... ... May 19, 2017 , ... Springfield, Vermont-based law firm ... Titled " Ten Good Reasons To Hire An Experienced Personal Injury Attorney, " the ... an accident or injury. As the article says. if someone is injured due ...
(Date:5/19/2017)... ... 19, 2017 , ... As a groundbreaking surgeon on the frontline of prostate ... screenings. Early detection of the disease, he says, can make a world of difference. ... , stands alongside the Georgia Comprehensive Cancer Control’s (GC3) Prostate Cancer Task Force and ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)...  Bayer announced today that the latest research from ... the 53 rd Annual Meeting of the American ... in Chicago . ... liver and thyroid cancers, as well as lymphomas, and ... trial of copanlisib in patients with relapsed or refractory ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: